Enroll in a clinical trial of an investigational medicine for lupus
If you or a loved one suffers from lupus, taking part in a clinical research study is an important step in potentially bringing new lupus drugs to patients. Without the involvement of lupus patients in clinical trials new treatments for lupus will not be possible.
Participate in a lupus clinical research study
Resolve Therapeutics is developing an investigational lupus therapy, called RSLV-132 which specifically removes molecules thought to be important in the inflammation associated with lupus without shutting down the immune system. It is hoped that by removing these molecules, inflammation will be reduced with fewer side effects.
RSLV-132 has successfully completed two clinical studies to investigate its safety and is currently enrolling patients with active lupus rash in a clinical research study. Please call us at 888-391-7570 to find out if this study is right for you.
To learn more about the clinical trial, call 888-391-7570
If you live close to one of these 12 leading rheumatology clinical study sites and would like to learn more about the clinical trial, please call the toll-free number above and a Resolve Therapeutics representative will be happy to speak with you to answer questions and provide more information.